Sabarubicin (MEN10755)-induced apoptosis is independent from mtDNA in A2780 human ovarian tumor cells

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4039-4046

  Bressan, Alessandro ^a   Nardelli, Federica ^a   Bellarosa, Daniela ^a   Bigioni, Mario ^a   Curcurù, Giuseppe ^a   Curatella, Barbara ^a   Crea, Attilio ^a   Maggi, Carlo Alberto ^b   Manzini, Stefano ^a   Binaschi, Monica ^a  

^a Menarini Ricerche SpA   (Italy)

^b NONE   (Italy)

Author keywords

0 cells; Anthracycline; Apoptosis; mtDNA

Indexed keywords

DOXORUBICIN; MITOCHONDRIAL DNA; SABARUBICIN; TENIPOSIDE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OVARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, SOUTHERN; CELL LINE, TUMOR; DISACCHARIDES; DNA, MITOCHONDRIAL; DOXORUBICIN; FEMALE; GENE EXPRESSION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 37549045938     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wang S, Konorew EA, Kotamraju S, Joseph J, Kalivendi S and Kalyanaraman B: Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. J Biol Chem 279(24): 25535-25543, 2004.
2. Sharples RA, Cullinane C and Phillips DR: Adriamycin-induced inhibition of mitochondrial-encoded polypeptides as a model system for the identification of hotspots for DNA-damaging agents. Anticancer Drug Des 15(3): 183-190, 2000.
3. Cullinane C, Cutts SM, Panousis C and Phillips DR: Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells. Nucleic Acids Res 28(4): 1019-1025, 2000.
4. Kim J-Y, Kim Y-H, Chang I, Kim S, Pak YK, Oh B-H, Yagita H, Jung YK, Oh YJ and Lee M-S: Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis. Oncogene 21: 3139-3148, 2002.
5. Lo S, Tolner B, Taanman J-W, Cooper JM, Gu M, Hatrley JA, Schapira AHV and Hochhauser D: Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents. Int J Oncol 27: 337-344, 2005.
6. Singh KK, Russell J, Sigala B, Zhang Y, Williams J and Keshav KF: Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 18: 6641-6646, 1999.
7. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC and Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA Nature 361(6410): 365-369, 1993.
8. Marchetti P, Susin SA, Decaudin D, Gamen S, Castedo M, Hirsch T, Zamzami N, Naval J, Senik A and Kroemer G: Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res 56(9): 2033-2038, 1996.
9. Wang J, Silva JP, Gustaffson CM, Rustin P and Larsson N-G: Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci USA 98(7): 4038-4043, 2001.
10. Bellarosa D, Ciucci A, Bullo A, Nardelli F, Manzini S, Maggi CA and Goso C: Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J Pharmacol Experiment Therapeut 296(2): 276-283, 2001.
11. Arcamone F, Animati F, Berettoni M, Bigioni M, Capranico G, Casazza AM, Caserini C, Cipollone A, De Cesare M, Franciotti M, Lombardi P, Madami A, Manzini S, Monteagudo E, Polizzi D, Pratesi G, Righetti SC, Salvatore C, Supino R and Zunino F: Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo. J Natl Cancer Inst 89(16): 1217-1223, 1997.
12. Modica-Napolitano JS, Koya K, Weisberg E, Brunelli BT, Li Y and Chen LB: Selective damage to carcinoma mitochondria by rhodacyanine MKT-077. Cancer Res 56: 544-550, 1996.
13. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi CA: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
14. Reers M, Smith TW and Chen LB: J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30: 4480-4486, 1991.
15. Low RL, Orton S and Friedman DB: A truncated form of DNA topoisomerase IIβ associates with the mtDNA genome in mammalian mitochondria. Eur J Biochem 270: 4173-4186, 2003.
16. Zhang H, Meng L-H and Pommier Y: Mitochondrial topoisomerases and alternative splicing of the human TOP1mt gene. Biochimie 89(4): 474-481, 2007.
17. Lebrecht D, Setzer B, Ketelsen U-P, Haberstroh J and Walker UA: Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 108: 2423-2429, 2003.
18. Lebrecht D, Setzer B, Rohrbach R and Walker UA: Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transpl 19: 329-336, 2004.
19. Bellarosa D, Binaschi M, Maggi CA and Goso C: Sabarubicin-(MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-κB) activation: effect of parthenolide on their cytotoxicity. Anticancer Res 25(3B): 2119-2128, 2005.
20. Fernandez-Silva P, Enriquez JA and Montoya J: Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 88: 41-56, 2003.
21. Larsen NB, Rasmussen M and Rasmussen LJ: Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion 5: 89-108, 2005.
22. Jiang S, Cai J, Wallace DC and Jones DP: Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA. J Biol Chem 274(42): 29905-29911, 1999.
23. Modica-Napolitano JS and Singh KK: Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 11: 1-19, 2002.
24. Park SY, Chang I, Kim J-Y, Kang SW, Park SH, Singh K and Lee M-S: Resistance of mitochondrial DNA-depleted cells against cell death. J Biol Chem 279(9): 7512-7520, 2004.